Pfizer

Pfizer

PFIZER

 ₹ 4,116.55
- ₹ 13.65
-0.33%

Market Sentiment
of Pfizer

TimelineReturnsVolume
Daily--
Weekly0.21%28,433
Monthly-5.34%6,97,601

Performance
of Pfizer

TimelineDailyWeeklyMonthly
PFIZER-0.21%-5.34%
Index--0.57%0.23%
Peer Avg.-2.42%5.36%
*Avg of index constituents

Fundamentals
of Pfizer

TimelinePEPBEV/EBIDTAROEROCEDiv. Yield
PFIZER32.506.950.0023.3029.780.00
Index35.445.9816.8116.9918.411.19
Peer Avg.0.000.000.000.000.000.00
*Avg of index constituents

Key Metrics
of Pfizer

MetricsSales GrowthProfit GrowthROEROCE
FY '21-2216.64%23.10%23.3029.78
FY '20-214.04%-2.26%17.1923.62
FY '19-203.37%18.66%15.8920.38

Shareholding Pattern
of Pfizer

PromotersFIIDIIPublicOthers
Promoters : 63.92%
FII : 2.2%
DII : 15.06%
Public : 18.82%
Others : 0%

Profit & Loss
of Pfizer

MetricsSalesExpenditureEBITDAPAT
FY '21-222,610.991,775.05898.59612.56
FY '20-212,238.551,526.15793.52497.61
FY '19-202,151.651,578.93756.74509.13
All values are in crores

Pfizer Share Price

Pfizer Limited is an Indian pharmaceutical company. The company's field of activity is the production, distribution, trade and export of medicines. The company has its own manufacturing facility in Goa. The company has several independent contract/third party manufacturers in India. Its product portfolio includes vaccines, anti-infective, cardiac, pain, maternal nutrition, gastrointestinal, anti-pregnancy, anti-inflammatory, anti-nutritional and anti-immune vaccines, and respiratory vaccines. The company's vaccine business focuses on Prevenar 13, a pneumococcal conjugate vaccine administered to infants six weeks of age and older as part of the primary immunisation program, infants, adolescents, adults and the elderly. Its inflammation and immunology portfolio includes two advanced therapies serving patients suffering from chronic immune-related diseases such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.

FAQs

Want to learn and earn in Stocks?